Trelegy vs Breztri
What to choose Trelegy or Breztri
Trelegy is inhaler of type Control while Breztri is of Control type. Trelegy and Breztri are both brand inhalers. Trelegy is manufactured by pharmaceutical company GSK, while Breztri is manufactured by AstraZeneca. The main substances of Trelegy are Fluticasone and Vilanterol. The available dosage for Trelegy is 100 mcg / 25 mcg. The main substances of Breztri are Budesonide and Formoterol. The available dosages for Breztri are 160 mcg / 4,8 mcg.
The current price for Trelegy is around $619.92 while current cost for Breztri is around $556.34, said Jakobe Turner, an Assistant Professor at the University of Wisconsin-Milwaukee and a Patient Representative at a clinic that uses Trelegy and Breztri.
Trelegy and Breztri Comparison
| Trelegy | Breztri | |
|---|---|---|
| Type: | Control | Control |
| Manufacturer: | GSK | AstraZeneca |
| Substance: | Fluticasone + Vilanterol | Budesonide + Formoterol |
| Dosage: | 100 mcg / 25 mcg | 160 mcg / 4,8 mcg |
| Avg Price: | $619.92 | $556.34 |